Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chemotherapy agents in human epidermal growth factor receptor 2-positive breast cancer: time to step out of the limelight.

Chemotherapy agents in human epidermal growth factor receptor 2-positive breast cancer: time to step out of the limelight. J Clin Oncol. 2011 Jan 20; 29(3):251-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.